Abstract
Higher incidences of osteoporosis and osteopenia are found in cancer patients, particularly in women receiving aromatase inhibitors or with chemotherapy-induced ovarian failure, or in men with prostate cancer and androgen deprivation therapy. Therefore, management of long-term bone health is emerging as an important aspect of comprehensive cancer care. Patients with cancer typically have a number of additional risk factors for osteoporosis that should prompt screening, regardless of patient age or sex. Maintaining bone health requires a broad knowledge base, including understanding underlying bone metabolism and how it is affected by both cancer itself and the drugs used to treat cancer, the effect of chemotherapy-induced menopause on bone health, bone markers and imaging techniques used to assess bone health, therapeutic strategies to maintain bone health, and treatment of bone metastases, including surgery for pathologic fractures. Multiple members of the healthcare team may need to be involved in education and care of the patient. This report summarizes discussion of these and other issues regarding bone health and cancer care from the NCCN Bone Health and Cancer Care Task Force meeting in early 2006.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S-1-S-20 |
| Journal | JNCCN Journal of the National Comprehensive Cancer Network |
| Volume | 4 |
| Issue number | SUPPL. 2 |
| State | Published - May 1 2006 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Oncology
Cite this
}
NCCN Task Force report : Bone health and cancer care. / Theriault, Richard L.; Biermann, J. Sybil; Brown, Elizabeth; Brufsky, Adam; Demers, Laurence; Grewal, Ravinder K.; Guise, Theresa; Jackson, Rebecca; McEnery, Kevin; Podoloff, Donald; Ravdin, Peter; Shapiro, Charles L.; Smith, Matthew; Van Poznak, Catherine H.
In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 4, No. SUPPL. 2, 01.05.2006, p. S-1-S-20.Research output: Contribution to journal › Article
TY - JOUR
T1 - NCCN Task Force report
T2 - Bone health and cancer care
AU - Theriault, Richard L.
AU - Biermann, J. Sybil
AU - Brown, Elizabeth
AU - Brufsky, Adam
AU - Demers, Laurence
AU - Grewal, Ravinder K.
AU - Guise, Theresa
AU - Jackson, Rebecca
AU - McEnery, Kevin
AU - Podoloff, Donald
AU - Ravdin, Peter
AU - Shapiro, Charles L.
AU - Smith, Matthew
AU - Van Poznak, Catherine H.
PY - 2006/5/1
Y1 - 2006/5/1
N2 - Higher incidences of osteoporosis and osteopenia are found in cancer patients, particularly in women receiving aromatase inhibitors or with chemotherapy-induced ovarian failure, or in men with prostate cancer and androgen deprivation therapy. Therefore, management of long-term bone health is emerging as an important aspect of comprehensive cancer care. Patients with cancer typically have a number of additional risk factors for osteoporosis that should prompt screening, regardless of patient age or sex. Maintaining bone health requires a broad knowledge base, including understanding underlying bone metabolism and how it is affected by both cancer itself and the drugs used to treat cancer, the effect of chemotherapy-induced menopause on bone health, bone markers and imaging techniques used to assess bone health, therapeutic strategies to maintain bone health, and treatment of bone metastases, including surgery for pathologic fractures. Multiple members of the healthcare team may need to be involved in education and care of the patient. This report summarizes discussion of these and other issues regarding bone health and cancer care from the NCCN Bone Health and Cancer Care Task Force meeting in early 2006.
AB - Higher incidences of osteoporosis and osteopenia are found in cancer patients, particularly in women receiving aromatase inhibitors or with chemotherapy-induced ovarian failure, or in men with prostate cancer and androgen deprivation therapy. Therefore, management of long-term bone health is emerging as an important aspect of comprehensive cancer care. Patients with cancer typically have a number of additional risk factors for osteoporosis that should prompt screening, regardless of patient age or sex. Maintaining bone health requires a broad knowledge base, including understanding underlying bone metabolism and how it is affected by both cancer itself and the drugs used to treat cancer, the effect of chemotherapy-induced menopause on bone health, bone markers and imaging techniques used to assess bone health, therapeutic strategies to maintain bone health, and treatment of bone metastases, including surgery for pathologic fractures. Multiple members of the healthcare team may need to be involved in education and care of the patient. This report summarizes discussion of these and other issues regarding bone health and cancer care from the NCCN Bone Health and Cancer Care Task Force meeting in early 2006.
UR - http://www.scopus.com/inward/record.url?scp=33747605310&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747605310&partnerID=8YFLogxK
M3 - Article
C2 - 16737674
AN - SCOPUS:33747605310
VL - 4
SP - S-1-S-20
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
SN - 1540-1405
IS - SUPPL. 2
ER -